Results 71 to 80 of about 312 (124)

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico. [PDF]

open access: yesN Engl J Med, 2022
Dunkle LM   +33 more
europepmc   +1 more source

SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients. [PDF]

open access: yesJ Mol Cell Biol, 2022
Pontelli MC   +42 more
europepmc   +1 more source

The value of open-source clinical science in pandemic response: lessons from ISARIC. [PDF]

open access: yesLancet Infect Dis, 2021
ISARIC Clinical Characterisation Group.
europepmc   +1 more source

A View from the past into our collective future: the oncofertility consortium vision statement. [PDF]

open access: yesJ Assist Reprod Genet, 2021
Woodruff TK   +107 more
europepmc   +1 more source

Rapid subcellular calcium responses and dynamics by calcium sensor G-CatchER. [PDF]

open access: yesiScience, 2021
Reddish FN   +17 more
europepmc   +1 more source

Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical Trial.

open access: yesJAMA Netw Open, 2023
Áñez G   +18 more
europepmc   +1 more source

Impact of nasal and inhaled corticosteroids on SARS-CoV-2 infection susceptibility. [PDF]

open access: yesJ Allergy Clin Immunol
Rosas-Salazar C   +31 more
europepmc   +1 more source

X-Chromosome Association Study in Latin American Cohorts Identifies New Loci in Parkinson's Disease. [PDF]

open access: yesMov Disord, 2023
Leal TP   +49 more
europepmc   +1 more source

Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort. [PDF]

open access: yesElife, 2021
ISARIC Clinical Characterisation Group   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy